Finally, we discovered a novel FAT4 protein expression profile in cervical cancer and showed that FAT4 regulates immune editing, suggesting that the FAT4/β-catenin/STT3/PD-L1 signaling axis could be a potential target for cervical cancer. The gene discussed is CD274; the disease is cervical cancer.